KRAS, one gene present in some cancers, was considered “undruggable” for years.[1] Mutated KRAS is an important target for patients with non-small cell lung cancer (NSCLC) because it’s present in 20-25% of cases.[2] Finally, one drug, sotorasib (Lumakras), is approved to treat one mutant form of KRAS gene, KRAS G12C.[3] This mutation appears in...
Read More
Home »
sotorasib
sotorasib Posts on Medivizor
To receive all the
cutting-edge updates personally relevant to you
(free and private)
Categories
- Benign prostatic hyperplasia
- Blog
- Breast cancer
- Colorectal cancer
- Coronary artery disease
- Coronavirus / COVID-19
- Diabetes mellitus
- Erectile dysfunction
- Hodgkin's lymphoma
- Hypertension
- Infertility
- Kidney stones
- Leukemia
- Lung cancer
- Lymphoma
- Melanoma
- Men's Health
- Mental Health
- Multiple Myeloma
- Nocturia
- Non-Hodgkin lymphoma
- Overactive bladder
- Parkinson's Disease
- Prostate cancer
- Rheumatoid Arthritis
- Stroke
- Urinary incontinence
- Urinary tract infection
Recent Posts
- It’s Not “Only” Hair: Scalp Hair Loss
- Evaluating the effectiveness of a supplement with L-arginine and Pycnogenol for men with erectile dysfunction
- Erectile Dysfunction: Saturated Fats Can Ruin Your Sex Life
- Evaluating the effectiveness of holmium laser enucleation of the median lobe of the prostate on preserving sexual and urinary function in patients with benign prostatic hyperplasia.
- Evaluating the effectiveness and safety of salvage radiotherapy combined with hormone therapy in patients with biochemical recurrence of prostate cancer after prostate surgery.